logo

Pfizer Inc. (PFE)



Trade PFE now with
  Date
  Headline
10/21/2021 6:47:51 AM Pfizer And BioNTech Say Phase 3 Trial Data Shows High Efficacy Of Booster Dose Of Their COVID-19 Vaccine
10/15/2021 7:53:51 AM Pfizer's Abrocitinib Gets Positive CHMP Opinion For Treatment Of Adults With Moderate To Severe Atopic Dermatitis
10/7/2021 9:52:58 AM Pfizer Seeks Emergency Nod In U.S. For COVID-19 Vaccine For Children 5 To Below 12
10/6/2021 7:23:29 AM Voyager Therapeutics Announces Licensing Agreement With Pfizer
9/30/2021 6:48:55 AM Pfizer Says Japan's MHLW Approves CIBINQO For Adults And Adolescents With Moderate To Severe Atopic Dermatitis
9/29/2021 6:49:57 AM -Pfizer Reports Positive Top-line Results From Phase 3 Study Exploring Coadministration Of Prevnar 20
9/28/2021 6:49:57 AM Pfizer, BioNTech Submit Initial Data To FDA From Phase 2/3 Trial Trial Of COVID-19 Vaccine In Children 5 To <12 Years
9/28/2021 6:45:42 AM ViiV Healthcare: FDA Grants Priority Review To Cabotegravir NDA For Prevention Of HIV
9/28/2021 1:06:23 AM Valneva, Pfizer Announce Further Positive Phase 2 Results For Lyme Disease Vaccine Candidate VLA15